Brief: CelLBxHealth Says Board Expects To Be EBITDA Positive In 2028
BRIEF-CelLBxHealth Says Board Expects To Be EBITDA Positive In 2028 July 15 (Reuters) - Cellbxhealth PLC CLBX.L:
CELLBXHEALTH PLC - Q2 AND FIRST HALF YEAR RESULTS ENDED 30 JUNE 2026
CELLBXHEALTH - BOARD EXPECTS TO BE EBITDA POSITIVE IN 2028
CELLBXHEALTH - EXPECTS FY2026 REVENUES OF AT LEAST £2.1 MILLION, UP AT LEAST 50% OVER FY2025
Source text: ID:nRSO3458Ma
Further company coverage: CLBX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellbxhealth
See all newsBrief: Cellbxhealth Anticipates FY2027 Revenues Of £3 Million-£4 Million
Brief: Cellbxhealth Enters Master Services Agreement With Swiss Biotech
Master Services Agreement with Swiss biotech co
Q3 Trading Update and FY 2026 Outlook
Brief: Cellbxhealth Signs New Statement Of Work With US-Based Pharma Company